Objective: To evaluate the level of knowledge of the residents in medicine (RIM) about generic drugs (GDs), the factors that might influence their knowledge, and their perception and prescription attitudes towards GDs.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objective: To evaluate the level of knowledge of the residents in medicine (RIM) about generic drugs (GDs), the factors that might influence their knowledge, and their perception and prescription attitudes towards GDs.
📊
Key Findings & Data:Objective: To evaluate the level of knowledge of the residents in medicine (RIM) about generic drugs (GDs), the factors that might influence their knowledge, and their perception and prescription attitudes towards GDs.
💡
Conclusion & Impact:Objective: To evaluate the level of knowledge of the residents in medicine (RIM) about generic drugs (GDs), the factors that might influence their knowledge, and their perception and prescription attitudes towards GDs.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:muadil ilaç · jenerik ilaç · akılcı ilaç kullanımı
Abstract
Objective: To evaluate the level of knowledge of the residents in medicine (RIM) about generic drugs (GDs), the factors that might influence their knowledge, and their perception and prescription attitudes towards GDs.
Özet
Amaç: Bu çalışmada tıpta uzmanlık öğrencileri (TUÖ)’nin eşdeğer ilaç (Eİ)’a dair bilgi düzeylerinin, bilgi düzeylerini etkileyebilecek faktörlerin, Eİ hakkında düşünce ve reçeteleme tutumlarının değerlendirilmesi amaçlandı.
TAHİRLER, P., ÖNCÜ, Ş., ARICI, M. A., UÇKU, Ş. R., GELAL, A. (2019). EVALUATION OF THE KNOWLEDGE, PERCEPTION AND ATTITUDE OF RESIDENTS IN MEDICINE WORKING IN A UNIVERSITY HOSPITAL ABOUT GENERIC DRUGS. Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi, Cilt: 33 - Sayı: 2, 109–119. https://ajindex.com/articles/150614
Kwo EC, Kamat P, Steinman MA. Physician use of brand versus generic drug names in 1993-1994 and 2003-2004. Ann Pharmacother 2009;43:459-68. IMS Institute for Healthcare Informatics. The role of generic medicines in sustaining healthcare systems: A European perspective 2015. Available from: URL: http://www.apmgr.org/docs/IIHI_Generics_Healthcare_Brief.pdf (Erişim tarihi: 25 Ocak 2019).
Sacks CA, Lee CC, Kesselheim AS, Avorn J. Medicare spending on brand-name combination medications vs their generic constituents. JAMA 2018;320:650-6.
Wouters OJ, Kanavos PG, McKEE M. Comparing generic drug markets in Europe and the United States: prices, volumes, and spending. Milbank Q 2017;95:554-601.
Warraich HJ, Salami JA, Khera R, Valero-Elizondo J, Okunrintemi V, Nasir K. Trends in use and expenditures of brand-name atorvastatin after introduction of generic atorvastatin. JAMA Intern Med 2018;178:719-21.
Kjoenniksen I, Lindbaek M, Granas AG. Patients' attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci 2006;28:284-9.
Straka RJ, Keohane DJ, Liu LZ. Potential clinical and economic impact of switching branded medications to generics. Am J Ther 2017;24:e278-e289. Colgan S, Faasse K, Martin LR, Stephens MH, Grey A, Petrie KJ. Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review. BMJ Open 2015;5:e008915. Domeyer PJ, Aletras V, Anagnostopoulos F, Katsari V, Niakas D. Development and validation of a tool to assess knowledge and attitudes towards generic medicines among students in Greece: The ATtitude Towards GENerics (ATTOGEN) questionnaire. PLoS One 2017;12:e0188484. Dunne SS, Shannon B, Cullen W, Dunne CP. Beliefs, perceptions and behaviours of GPs towards generic medicines. Fam Pract 2014;31:467-74.
Fabiano V, Mameli C, Cattaneo D, et al. Perceptions and patterns of use of generic drugs among Italian Family Pediatricians: First round results of a web survey. Health Policy 2012;104:247-52.
Flood D, Mathieu I, Chary A, Garcia P, Rohloff P. Perceptions and utilization of generic medicines in Guatemala: a mixed-methods study with physicians and pharmacy staff. BMC Health Serv Res 2017;17:27. Lewek P, Smigielski J, Kardas P. Factors affecting the opinions of family physicians regarding generic drugs - a questionnaire based study. Bosn J Basic Med Sci 2015;15:45-50.
Riner B, Bussy A, Hélène-Pelage J, Moueza N, Lamy S, Carrère P. “No generics, Doctor!” The perspective of general practitioner